{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:07:34Z","timestamp":1786990054696,"version":"build-2736575974"},"reference-count":52,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,9,3]],"date-time":"2020-09-03T00:00:00Z","timestamp":1599091200000},"content-version":"vor","delay-in-days":2,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004386","name":"Universiti Malaya","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004386","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.heliyon.2020.e04856","type":"journal-article","created":{"date-parts":[[2020,9,13]],"date-time":"2020-09-13T22:55:24Z","timestamp":1600037724000},"page":"e04856","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"title":["Docking based screening and molecular dynamics simulations to identify potential selective PDE4B inhibitor"],"prefix":"10.1016","volume":"6","author":[{"given":"Mayasah","family":"Al-Nema","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1039-064X","authenticated-orcid":false,"given":"Anand","family":"Gaurav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vannajan Sanghiran","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.heliyon.2020.e04856_bib1","series-title":"Version 2.5. 5","author":"Accelrys","year":"2009"},{"key":"10.1016\/j.heliyon.2020.e04856_bib2","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.jmgm.2017.03.010","article-title":"Conformational and energy evaluations of novel peptides binding to dengue virus envelope protein","volume":"74","author":"Amir-Hassan","year":"2017","journal-title":"J.\u00a0Mol. Graph. Model."},{"key":"10.1016\/j.heliyon.2020.e04856_bib3","doi-asserted-by":"crossref","first-page":"453","DOI":"10.3797\/scipharm.1404-08","article-title":"Selective phosphodiesterase 4B inhibitors: a review","volume":"82","author":"Azam","year":"2014","journal-title":"Sci. Pharm."},{"key":"10.1016\/j.heliyon.2020.e04856_bib4","doi-asserted-by":"crossref","first-page":"17","DOI":"10.2174\/187152807780077318","article-title":"Highly selective phosphodiesterase 4 inhibitors for the treatment of allergic skin diseases and psoriasis","volume":"6","author":"Baumer","year":"2007","journal-title":"Inflamm. Allergy \u2013 Drug Targets"},{"key":"10.1016\/j.heliyon.2020.e04856_bib5","series-title":"Discovery Studio Modeling Environment","author":"BIOVIA","year":"2017"},{"key":"10.1016\/j.heliyon.2020.e04856_bib6","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.cellsig.2014.12.009","article-title":"Dimerization of cAMP phosphodiesterase-4 (PDE4) in living cells requires interfaces located in both the UCR1 and catalytic unit domains","volume":"27","author":"Bolger","year":"2015","journal-title":"Cell. Signal."},{"key":"10.1016\/j.heliyon.2020.e04856_bib7","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/nbt.1598","article-title":"Design of phosphodiesterase 4D (PDE4D) allosteric modulators for enhancing cognition with improved safety","volume":"28","author":"Burgin","year":"2010","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.heliyon.2020.e04856_bib8","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1016\/j.str.2004.10.004","article-title":"Structural basis for the activity of drugs that inhibit phosphodiesterases","volume":"12","author":"Card","year":"2004","journal-title":"Structure"},{"key":"10.1016\/j.heliyon.2020.e04856_bib9","series-title":"AMBER 14","author":"Case","year":"2014"},{"key":"10.1016\/j.heliyon.2020.e04856_bib10","doi-asserted-by":"crossref","first-page":"5493","DOI":"10.1074\/jbc.R200029200","article-title":"Cyclic AMP-specific PDE4 phosphodiesterases as critical components of cyclic AMP signaling","volume":"278","author":"Conti","year":"2003","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.heliyon.2020.e04856_bib11","doi-asserted-by":"crossref","first-page":"10089","DOI":"10.1063\/1.464397","article-title":"Particle mesh Ewald: an N\u22c5 log (N) method for Ewald sums in large systems","volume":"98","author":"Darden","year":"1993","journal-title":"J.\u00a0Chem. Phys."},{"key":"10.1016\/j.heliyon.2020.e04856_bib12","first-page":"7","article-title":"Pharmacophore-based virtual screening from Indonesian herbal database to finding new inhibitor of HDAC4 and HDAC7","volume":"10","author":"Erlina","year":"2018","journal-title":"J.\u00a0Young Pharm."},{"key":"10.1016\/j.heliyon.2020.e04856_bib13","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.ejphar.2005.12.059","article-title":"Phosphodiesterase inhibitors in airways disease","volume":"533","author":"Fan Chung","year":"2006","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.heliyon.2020.e04856_bib14","doi-asserted-by":"crossref","first-page":"4518","DOI":"10.1021\/acs.biochem.8b00336","article-title":"Identification of a PDE4-specific pocket for the design of selective inhibitors","volume":"57","author":"Feng","year":"2018","journal-title":"Biochemistry"},{"key":"10.1016\/j.heliyon.2020.e04856_bib15","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.cellsig.2013.12.003","article-title":"Structural basis for the design of selective phosphodiesterase 4B inhibitors","volume":"26","author":"Fox","year":"2014","journal-title":"Cell. Signal."},{"key":"10.1016\/j.heliyon.2020.e04856_bib16","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.bmcl.2013.12.076","article-title":"Identification of the 5, 5-dioxo-7, 8-dihydro-6H-thiopyrano [3, 2-d] pyrimidine derivatives as highly selective PDE4B inhibitors","volume":"24","author":"Goto","year":"2014","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.heliyon.2020.e04856_bib17","doi-asserted-by":"crossref","first-page":"3325","DOI":"10.1016\/j.bmcl.2013.03.104","article-title":"Identification of the fused bicyclic 4-amino-2-phenylpyrimidine derivatives as novel and potent PDE4 inhibitors","volume":"23","author":"Goto","year":"2013","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.heliyon.2020.e04856_bib18","doi-asserted-by":"crossref","first-page":"4031","DOI":"10.1016\/j.bmcl.2014.06.002","article-title":"Discovery of triazines as selective PDE4B versus PDE4D inhibitors","volume":"24","author":"Hagen","year":"2014","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.heliyon.2020.e04856_bib19","doi-asserted-by":"crossref","first-page":"174501","DOI":"10.1063\/1.4872239","article-title":"Structure and dynamics of TIP3P, TIP4P, and TIP5P water near smooth and atomistic walls of different hydroaffinity","volume":"140","author":"Harrach","year":"2014","journal-title":"J.\u00a0Chem. Phys."},{"key":"10.1016\/j.heliyon.2020.e04856_bib20","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.tibs.2009.09.007","article-title":"Underpinning compartmentalised cAMP signalling through targeted cAMP breakdown","volume":"35","author":"Houslay","year":"2010","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.heliyon.2020.e04856_bib21","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1016\/S1359-6446(05)03622-6","article-title":"Keynote review: phosphodiesterase-4 as a therapeutic target","volume":"10","author":"Houslay","year":"2005","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.heliyon.2020.e04856_bib22","doi-asserted-by":"crossref","first-page":"13220","DOI":"10.1021\/bi034653e","article-title":"The crystal structure of AMP-bound PDE4 suggests a mechanism for phosphodiesterase catalysis","volume":"42","author":"Huai","year":"2003","journal-title":"Biochemistry"},{"key":"10.1016\/j.heliyon.2020.e04856_bib23","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.neuroscience.2006.09.026","article-title":"Rolipram: a specific phosphodiesterase 4 inhibitor with potential antipsychotic activity","volume":"144","author":"Kanes","year":"2007","journal-title":"Neuroscience"},{"key":"10.1016\/j.heliyon.2020.e04856_bib24","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.cellsig.2015.10.005","article-title":"Protein-protein interactions of PDE4 family members - functions, interactions and therapeutic value","volume":"28","author":"Klussmann","year":"2016","journal-title":"Cell. Signal."},{"key":"10.1016\/j.heliyon.2020.e04856_bib25","doi-asserted-by":"crossref","first-page":"5336","DOI":"10.1016\/j.bmc.2009.03.061","article-title":"Identification of PDE4B over 4D subtype-selective inhibitors revealing an unprecedented binding mode","volume":"17","author":"Kranz","year":"2009","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.heliyon.2020.e04856_bib26","doi-asserted-by":"crossref","first-page":"3786","DOI":"10.1021\/jm000241h","article-title":"Binding of a diverse set of ligands to avidin and streptavidin: an accurate quantitative prediction of their relative affinities by a combination of molecular mechanics and continuum solvent models","volume":"43","author":"Kuhn","year":"2000","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.heliyon.2020.e04856_bib27","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/S0006-8993(01)03023-2","article-title":"Localization of phosphodiesterase-4 isoforms in the medulla and nodose ganglion of the squirrel monkey","volume":"920","author":"Lamontagne","year":"2001","journal-title":"Brain Res."},{"key":"10.1016\/j.heliyon.2020.e04856_bib28","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.3389\/fphar.2018.01048","article-title":"Phosphodiesterase-4 inhibitors for the treatment of inflammatory diseases","volume":"9","author":"Li","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.heliyon.2020.e04856_bib29","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1080\/07391102.2015.1070749","article-title":"Discover natural compounds as potential phosphodiesterase-4B inhibitors via computational approaches","volume":"34","author":"Li","year":"2016","journal-title":"J.\u00a0Biomol. Struct. Dyn."},{"key":"10.1016\/j.heliyon.2020.e04856_bib30","doi-asserted-by":"crossref","first-page":"184114","DOI":"10.1063\/1.4901119","article-title":"Tuning the smooth particle mesh Ewald sum: application on ionic solutions and dipolar fluids","volume":"141","author":"Linse","year":"2014","journal-title":"J.\u00a0Chem. Phys."},{"key":"10.1016\/j.heliyon.2020.e04856_bib31","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.ddtec.2004.11.007","article-title":"Lead-and drug-like compounds: the rule-of-five revolution","volume":"1","author":"Lipinski","year":"2004","journal-title":"Drug Discov. Today Technol."},{"key":"10.1016\/j.heliyon.2020.e04856_bib32","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(96)00423-1","article-title":"Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings","volume":"23","author":"Lipinski","year":"1997","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.heliyon.2020.e04856_bib33","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.jmgm.2017.07.017","article-title":"Binding free energy calculations using MMPB\/GBSA approaches for PAMAM-G4-drug complexes at neutral, basic and acid pH conditions","volume":"76","author":"Mart\u00ednez-Mu\u00f1oz","year":"2017","journal-title":"J.\u00a0Mol. Graph. Model."},{"key":"10.1016\/j.heliyon.2020.e04856_bib34","doi-asserted-by":"crossref","first-page":"3174","DOI":"10.1016\/j.bmcl.2009.04.121","article-title":"Discovery of selective PDE4B inhibitors","volume":"19","author":"Naganuma","year":"2009","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.heliyon.2020.e04856_bib35","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.tips.2004.01.003","article-title":"Antidepressant effects of inhibitors of cAMP phosphodiesterase (PDE4)","volume":"25","author":"O'Donnell","year":"2004","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.heliyon.2020.e04856_bib36","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S0891-0618(00)00097-1","article-title":"Phosphodiesterase type 4 isozymes expression in human brain examined by in situ hybridization histochemistry and[3H]rolipram binding autoradiography. Comparison with monkey and rat brain","volume":"20","author":"Perez-Torres","year":"2000","journal-title":"J.\u00a0Chem. Neuroanat."},{"key":"10.1016\/j.heliyon.2020.e04856_bib37","doi-asserted-by":"crossref","first-page":"3817","DOI":"10.1529\/biophysj.106.097782","article-title":"Refinement of the AMBER force field for nucleic acids: improving the description of \u03b1\/\u03b3 conformers","volume":"92","author":"P\u00e9rez","year":"2007","journal-title":"Biophys. J."},{"key":"10.1016\/j.heliyon.2020.e04856_bib38","doi-asserted-by":"crossref","first-page":"259","DOI":"10.3389\/fphar.2020.00259","article-title":"Inhaled phosphodiesterase 4 (PDE4) inhibitors for inflammatory respiratory diseases","volume":"11","author":"Phillips","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.heliyon.2020.e04856_bib39","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1038\/aps.2012.21","article-title":"Pharmacophore-based virtual screening and density functional theory approach to identifying novel butyrylcholinesterase inhibitors","volume":"33","author":"Sakkiah","year":"2012","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.heliyon.2020.e04856_bib40","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1002\/9781119161110.ch20","article-title":"3D pharmacophore modeling techniques in computer-aided molecular design using LigandScout","volume":"281","author":"Seidel","year":"2017","journal-title":"Tutorials Chemoinform"},{"key":"10.1016\/j.heliyon.2020.e04856_bib41","doi-asserted-by":"crossref","first-page":"117","DOI":"10.2174\/1570163812666150702123018","article-title":"Reliability of virtual screening methods in prediction of PDE4Binhibitor activity","volume":"12","author":"Shubina","year":"2015","journal-title":"Curr. Drug Discov. Technol."},{"key":"10.1016\/j.heliyon.2020.e04856_bib42","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0162-3109(00)00185-5","article-title":"Immunosuppressive and anti-inflammatory effects of cyclic AMP phosphodiesterase (PDE) type 4 inhibitors","volume":"47","author":"Souness","year":"2000","journal-title":"Immunopharmacology"},{"key":"10.1016\/j.heliyon.2020.e04856_bib43","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1038\/bjp.2008.307","article-title":"PDE4 inhibitors: current status","volume":"155","author":"Spina","year":"2008","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.heliyon.2020.e04856_bib44","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jtbi.2016.01.007","article-title":"Pharmacophore modeling, 3D-QSAR and docking study of 2-phenylpyrimidine analogues as selective PDE4B inhibitors","volume":"394","author":"Tripuraneni","year":"2016","journal-title":"J.\u00a0Theor. Biol."},{"key":"10.1016\/j.heliyon.2020.e04856_bib45","doi-asserted-by":"crossref","first-page":"5995","DOI":"10.1021\/jm5004914","article-title":"Ligand-based pharmacophore modeling and virtual screening for the discovery of novel 17\u03b2-hydroxysteroid dehydrogenase 2 inhibitors","volume":"57","author":"Vuorinen","year":"2014","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.heliyon.2020.e04856_bib46","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1042\/BJ20070970","article-title":"Structures of the four subfamilies of phosphodiesterase-4 provide insight into the selectivity of their inhibitors","volume":"408","author":"Wang","year":"2007","journal-title":"Biochem. J."},{"key":"10.1016\/j.heliyon.2020.e04856_bib47","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/S0026-895X(24)26397-5","article-title":"Phosphodiesterase 4B2 is the predominant phosphodiesterase species and undergoes differential regulation of gene expression in human monocytes and neutrophils","volume":"56","author":"Wang","year":"1999","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.heliyon.2020.e04856_bib48","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1021\/ci049885e","article-title":"LigandScout: 3-D pharmacophores derived from protein-bound ligands and their use as virtual screening filters","volume":"45","author":"Wolber","year":"2005","journal-title":"J.\u00a0Chem. Inf. Model."},{"key":"10.1016\/j.heliyon.2020.e04856_bib49","doi-asserted-by":"crossref","first-page":"2910","DOI":"10.1080\/07391102.2016.1234417","article-title":"Structure-based design of selective phosphodiesterase 4B inhibitors based on ginger phenolic compounds","volume":"35","author":"Xing","year":"2017","journal-title":"J.\u00a0Biomol. Struct. Dyn."},{"key":"10.1016\/j.heliyon.2020.e04856_bib50","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1126\/science.288.5472.1822","article-title":"Atomic structure of PDE4: insights into phosphodiesterase mechanism and specificity","volume":"288","author":"Xu","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.heliyon.2020.e04856_bib51","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1046\/j.1432-1327.2001.01866.x","article-title":"Genomic organization of the human phosphodiesterase PDE11A gene. Evolutionary relatedness with other PDEs containing GAF domains","volume":"268","author":"Yuasa","year":"2001","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.heliyon.2020.e04856_bib52","doi-asserted-by":"crossref","first-page":"12439","DOI":"10.1038\/s41598-017-12031-0","article-title":"Understanding the differences of the ligand binding\/unbinding pathways between phosphorylated and non-phosphorylated ARH1 using molecular dynamics simulations","volume":"7","author":"Zhu","year":"2017","journal-title":"Sci. Rep."}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844020316996?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844020316996?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T08:40:15Z","timestamp":1769157615000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844020316996"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":52,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["S2405844020316996"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2020.e04856","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Docking based screening and molecular dynamics simulations to identify potential selective PDE4B inhibitor","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2020.e04856","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e04856"}}